Investigator Global Assessment (IGA) of Actinic Keratosis (AK) Among Patients Administered Tirbanibulin in Real-World Community Practices across the U.S., and Clinician Likelihood to Consider Tirbanibulin Again for Future AK Treatments (PROAK Study). J of Skin 2023, 7 (2), s162. https://doi.org/10.25251/skin.7.supp.162.